Esther Hulleman

Publications

• Development of Transient Radioresistance During Fractionated Irradiation in Vitro
  Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology. Apr, 2020  |   Pubmed ID: 32344261
• Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2020  |   Pubmed ID: 32165429
• MEK/MELK Inhibition and Blood-brain Barrier Deficiencies in Atypical Teratoid/rhabdoid Tumors
  Neuro-oncology. 01, 2020  |   Pubmed ID: 31504799
• Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy?
  Frontiers in Oncology. 2019  |   Pubmed ID: 31970083
• Celastrol-induced Degradation of FANCD2 Sensitizes Pediatric High-grade Gliomas to the DNA-crosslinking Agent Carboplatin
  EBioMedicine. Dec, 2019  |   Pubmed ID: 31735550
• Preclinical Therapeutic Targets in Diffuse Midline Glioma
  Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 05, 2019  |   Pubmed ID: 31202081
• An Efficient Method for the Transduction of Primary Pediatric Glioma Neurospheres
  MethodsX. 2018  |   Pubmed ID: 30622915
• MELK Inhibition in Diffuse Intrinsic Pontine Glioma
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 11, 2018  |   Pubmed ID: 30061363
• IL-13 Receptors As Possible Therapeutic Targets in Diffuse Intrinsic Pontine Glioma
  PloS One. 2018  |   Pubmed ID: 29621254
• Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma
  Cell Reports. 03, 2018  |   Pubmed ID: 29562177
• Signaling Pathways and Mesenchymal Transition in Pediatric High-grade Glioma
  Cellular and Molecular Life Sciences : CMLS. Mar, 2018  |   Pubmed ID: 29164272
• Deceptive Morphologic and Epigenetic Heterogeneity in Diffuse Intrinsic Pontine Glioma
  Oncotarget. 09, 2017  |   Pubmed ID: 28947983
• Culture Methods of Diffuse Intrinsic Pontine Glioma Cells Determine Response to Targeted Therapies
  Experimental Cell Research. 11, 2017  |   Pubmed ID: 28947132
• Multiregional Tumor Drug-uptake Imaging by PET and Microvascular Morphology in End-stage Diffuse Intrinsic Pontine Glioma
  Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Aug, 2017  |   Pubmed ID: 28818988
• A Chemical Screen for Medulloblastoma Identifies Quercetin As a Putative Radiosensitizer
  Oncotarget. Jun, 2016  |   Pubmed ID: 26967057
• Functionally Defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma
  Nature Medicine. Jun, 2015  |   Pubmed ID: 25939062
• A Dual Program for Translation Regulation in Cellular Proliferation and Differentiation
  Cell. Sep, 2014  |   Pubmed ID: 25215487
• Identification of Temozolomide Resistance Factors in Glioblastoma Via Integrative MiRNA/mRNA Regulatory Network Analysis
  Scientific Reports. Jun, 2014  |   Pubmed ID: 24919120
• EFEMP1 Induces γ-secretase/Notch-mediated Temozolomide Resistance in Glioblastoma
  Oncotarget. Jan, 2014  |   Pubmed ID: 24495907
• EphB2 Activity Plays a Pivotal Role in Pediatric Medulloblastoma Cell Adhesion and Invasion
  Neuro-oncology. Sep, 2012  |   Pubmed ID: 22723427
• EZH2-regulated DAB2IP is a Medulloblastoma Tumor Suppressor and a Positive Marker for Survival
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2012  |   Pubmed ID: 22696229
• PARP Inhibition Sensitizes Childhood High Grade Glioma, Medulloblastoma and Ependymoma to Radiation
  Oncotarget. Dec, 2011  |   Pubmed ID: 22184287
• Blood Platelets Contain Tumor-derived RNA Biomarkers
  Blood. Sep, 2011  |   Pubmed ID: 21832279
• MiR-101 is Down-regulated in Glioblastoma Resulting in EZH2-induced Proliferation, Migration, and Angiogenesis
  Oncotarget. Dec, 2010  |   Pubmed ID: 21321380